| Line item | 2025-08-31 FY | 2024-08-31 FY | 2024-02-05 FY | 2023-08-31 FY | 2022-08-31 FY | 2021-08-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | $0.00 | – | $0.00 | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $2.36M | $2.61M | – | $2.31M | $4.63M | $7.94M |
| R&D | $621.88K | $593.99K | – | $764.83K | $1.09M | $1.66M |
| SG&A | $1.73M | $2.01M | $26.75K | $1.55M | $3.54M | $6.28M |
| Operating Income | -$2.36M | -$2.61M | – | -$2.31M | -$4.63M | -$7.94M |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | $0.00 | – | $0.00 | – | – |
| Net Income | -$2.26M | -$3.46M | – | -$2.40M | -$4.95M | -$7.91M |
| EPS (basic) | -0.0400 | -0.0600 | – | -0.0400 | -0.0900 | -0.1500 |
| EPS (diluted) | -0.0400 | -0.0600 | – | -0.0400 | -0.0900 | -0.1500 |
| Shares (diluted) | $55.82M | $53.20M | – | $53.20M | $53.20M | $26.02M |